Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-08
1998-12-01
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514342, A61K 3144, A61K 3142
Patent
active
058439706
ABSTRACT:
This invention relates to a second medical use of thiazolidine compounds having anti-diabetic properties. These compounds are also of use for the control of essential hypertension.
REFERENCES:
patent: 4444779 (1984-04-01), Kawamatsu et al.
patent: 4461902 (1984-07-01), Kawamatsu et al.
patent: 4486594 (1984-12-01), Kawamatsu et al.
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4582839 (1986-04-01), Meguro et al.
patent: 4703052 (1987-10-01), Eggler et al.
patent: 4725610 (1988-02-01), Meguro et al.
patent: 4762849 (1988-08-01), Grisar et al.
patent: 4775687 (1988-10-01), Meguro et al.
patent: 4791125 (1988-12-01), Clark
patent: 4798835 (1989-01-01), Krupp et al.
patent: 4812570 (1989-03-01), Meguro et al.
patent: 4880824 (1989-11-01), Press et al.
patent: 4962117 (1990-10-01), Young et al.
patent: 5002953 (1991-03-01), Hindley
patent: 5063240 (1991-11-01), Hindley
Kurtz, T.W., et al., "The Zucker Fatty Rat as a Genetic Model of Obesity and Hypertension," Hypertension 13:896-901 (1989).
Reaven, G.M., et al., "Attenuation of Fructose-Induced Hypertension in Rats by Exercise Training," Hypertension 12: 129-132 (1988).
Mondon, C.E. and Reaven, G.M., "Preliminary Report: Evidence of Abnormalities of Insulin Metabolism in Rats with Spontaneous Hypertension," Metabolism 37:303-305 (1988).
Hwang, I., et al., "Fructose-Induced Insulin Resistance and Hypertension in Rats," Hypertension 10: 512-516 (1987).
Tedde, R., et al., "Antihypertensive Effect of Insulin Reduction in Diabetic-Hypertensive Patients," Amer. J. Hypertension 2:163-170 (1989).
Hall, J.E., et al. "Does Chronic Hyperinsulinemia Cause Hypertension?" Amer. J. Hypertension 2:171-173 (1989).
Zavaroni, I., et al., "Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose Tolerance," N. Eng. J. Med. 320:702-706 (1989).
Ferrannini, E., et al., "Insulin Resistance in Essential Hypertension," N. Eng. J. Med. 317:350-357 (1987).
Fuh, M., et al., "Abnormalities of Carbohydrate and Lipid Metabolism in Patients with Hypertension," Arch. Intern. Med. 147:1035-1038 (1987).
Reaven, G.M. and Hoffman, B.B., "Occasional Survey: A Role for Insulin in the Aetiology and Course of Hypertension?" Lancet pp. 435-436, Aug. 22, 1987.
Zavaroni, I., et al., "Evidence that Multiple Risk Factors for Coronary Artery Disease Exist in Persons with Abnormal Glucose Tolerance," Amer. J. Med. 83:609-612 (1987).
Manicardi, V., et al., "Evidence for an Association of High Blood Pressure and Hyperinsulinemia in Obese Man," J. Clin. Endocrinol. Metab. 62:1302-1304 (1986).
Lucas, C.P., et al., "Insulin and Blood Pressure in Obesity," Hypertension 7:702-706 (1985).
Dustan, H.P., "Mechanisms of Hypertension Associated with Obesity," Ann. Intern. Med. 98:860-864 (1983).
Reaven, G.M. and Hoffman, B.B., "Hypertension: A Disease of Carbohydrate and Lipoprotein Metabolism," The Kidney 29:19-23 (1988).
Foster, D.W., "Insulin Resistance--A Secret Killer?" N. Eng. J. Med. 320:733-734 (1989).
Reaven, G.M., "Banting Lecture: Role of Insulin Resistance in Human Disease," Diabetes 37:1595-1607 (1988).
Colca, J.R., et al., "Ciglitazone, a Hypoglycemic Agent: Early Effects on the Pancreatic Islets of Ob/Ob Mice," Metabolism 37:276-280 (1988).
Chang, A.Y., et al., "Ciglitazone, a New Hypoglycemic Agent," Diabetes 32:830-838 (1983).
Rocchini, A.P., et al., "The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents," N. Eng. J. Med. 321:580-585 (1989).
DeFronzo, R.A., "The Effect of Insulin on Renal Sodium Metabolism," Diabetologia 21:165-171 (1981).
Pershadsingh, H.A. and Kurtz, T.W., "Letter to:" N. Eng. J. Med. 318:383-384 (1988).
Pershadsingh, H.A. and McDonald, J.M., "Hormone-Receptor Coupling and the Molecular Mechanism of Insulin Action in the Adipocyte: A Paradigm for Ca.sup.2+ Homeostasis in the Initiation of the Insulin-Induced Metabolic Cascade," Cell Calcium 5:111-130 (1984).
Klip, A., "Is Intracellular Ca.sup.2+ Involved in Insulin Stimulation of Sugar Transport? Fact and Prejudice," Canad. J. Biochem. Cell. Biol. 62:1228-1236 (1984).
Sugiyama, T., et al., "The Elevation of the Cytoplasmic Calcium Ions in Vascular Smmoth Muscle Cells in SHR--Measurement of the Free Calcium Ions in Single Living Cells by Lasermicrofluorospectrometry," Biochem. Biophys. Res. Comm. 141:340-345 (1986).
Kurtz Theodore W.
Pershadsingh Harrihar A.
LandOfFree
Thiazolidine derivatives for the treatment of hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidine derivatives for the treatment of hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidine derivatives for the treatment of hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2395980